Trials / Conditions / Refractory Lymphoblastic Lymphoma
Refractory Lymphoblastic Lymphoma
4 registered clinical trials studyying Refractory Lymphoblastic Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Re NCT07166419 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Terminated | Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Ly NCT05032183 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lympho NCT03136146 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lym NCT01658007 | Children's Hospital Medical Center, Cincinnati | EARLY_Phase 1 |